#Breaking: #Biogen is cutting the wholesale price of its #Alzheimer’s drug #Aduhelm in half in the U.S

Biogen is cutting the wholesale price of its Alzheimer’s drug Aduhelm in half in the U.S., a move that comes after the treatment’s high cost spurred concerns that it could strain Medicare and insurers https://t.co/mLVv7WzyaN

— Bloomberg (@business) December 20, 2021

Source: Twitter